Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12707572 | 0.80 | ALDH1A1 (0.61) | ALDH1A1RECQLHSD17B10TSHRCA12 | |
| SCHEMBL177790 | 0.80 | ALDH1A1 (1.00) | ALDH1A1RECQLHSD17B10CA12CA2 | |
| Hydrochloric Acid SCHEMBL5198585 | 0.78 | ALDH1A1 (0.95) | ALDH1A1RECQLHSD17B10CA12CA2 | |
| SCHEMBL27803677 | 0.78 | ALDH1A1 (0.95) | ALDH1A1RECQLHSD17B10CA12CA2 | |
| Benzene SCHEMBL27915918 | 0.77 | ALDH1A1 (0.91) | ALDH1A1RECQLHSD17B10CA12CA2 | |
| SCHEMBL3266073 | 0.77 | ALDH1A1 (0.57) | ALDH1A1RECQLHSD17B10TSHRCA12 | |
| Methyl Alcohol SCHEMBL27669635 | 0.77 | ALDH1A1 (0.91) | ALDH1A1RECQLHSD17B10CA12CA2 | |
| SCHEMBL153943 | 0.76 | TSHR (0.67) | ALDH1A1RECQLHSD17B10TSHRCA12 | |
| SCHEMBL9139800 | 0.75 | ALDH1A1 (0.88) | ALDH1A1RECQLHSD17B10CA12CA2 | |
| Nitric Acid SCHEMBL31529980 | 0.74 | ALDH1A1 (0.67) | ALDH1A1RECQLHSD17B10TSHRCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11851685-B2 | Zwitterion buffer containing compositions and uses in electroanalytical devices and methods | ROCHE DIABETES CARE, INC. (US) | 2023-12-26 | — | — | US | claimed |
| US-6821786-B2 | HOME/SELF-DIAGNOSIS; MICROTRACINGS | FUTURE DATA INC. | 2004-11-23 | — | — | US | claimed |
| US-20030203495-A1 | Diagnostic test for elemental imbalances | FUTURE DATA INC. | 2003-10-30 | — | — | US | claimed |
| US-5858691-A | Method and agent for the simultaneous colorimetric and electrochemical measurement of an analyte | BOEHRINGER MANNHEIM GMBH (DE) | 1999-01-12 | — | — | US | claimed |
| EP-0851928-A1 | DszD UTILIZATION IN DESULFURIZATION OF DBT BY RHODOCOCCUS sp. IGTS8 | ENERGY BIOSYSTEMS CORPORATION (US) | 1998-07-08 | — | — | EP | claimed |
| WO-1997011185-A1 | DszD UTILIZATION IN DESULFURIZATION OF DBT BY RHODOCOCCUS sp. IGTS8 | ENERGY BIOSYSTEMS CORPORATION (US) | 1997-03-27 | — | — | WO | claimed |
| WO-2024135708-A1 | METHOD FOR PRODUCING COMPOUND, POLYMER, COMPOSITION, AND PATTERN FORMATION METHOD | 三菱瓦斯化学株式会社 | 2024-06-27 | — | — | WO | disclosed |
| US-11851685-B2 | Zwitterion buffer containing compositions and uses in electroanalytical devices and methods | ROCHE DIABETES CARE, INC. (US) | 2023-12-26 | — | — | US | disclosed |
| US-20230174688-A1 | COMPOUND, (CO)POLYMER, COMPOSITION, METHOD FOR FORMING RESIST PATTERN, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING (CO)POLYMER | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-06-08 | — | — | US | disclosed |
| US-20220275348-A1 | ZWITTERION BUFFER CONTAINING COMPOSITIONS AND USES IN ELECTROANALYTICAL DEVICES AND METHODS | ROCHE DIABETES CARE, INC. | 2022-09-01 | — | — | US | disclosed |
| US-20220119336-A1 | COMPOUND, (CO)POLYMER, COMPOSITION, METHOD FOR FORMING PATTERN, AND METHOD FOR PRODUCING COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-04-21 | — | — | US | disclosed |
| EP-3388824-B1 | METHODS OF DETECTING HIGH ANTIOXIDANT LEVELS DURING ELECTROCHEMICAL MEASUREMENTS AND FAILSAFING AN ANALYTE CONCENTRATION THEREFROM AS WELL AS DEVICES AND SYSTEMS INCORPORTING THE SAME | ROCHE DIABETES CARE GMBH (DE) | 2021-04-14 | — | — | EP | disclosed |
| WO-2020137935-A1 | COMPOUND, (CO)POLYMER, COMPOSITION, PATTERN FORMING METHOD, AND COMPOUND PRODUCTION METHOD | 三菱瓦斯化学株式会社 | 2020-07-02 | — | — | WO | disclosed |
| US-20020142480-A1 | Surface-enhanced spectroscopy-active sandwich nanoparticles | SURROMED, INC. | 2002-10-03 | — | — | US | disclosed |
| US-5858691-A | Method and agent for the simultaneous colorimetric and electrochemical measurement of an analyte | BOEHRINGER MANNHEIM GMBH (DE) | 1999-01-12 | — | — | US | disclosed |
| US-5846813-A | DszD utilization in desulfurization of DBT by rhodococcus sp. IGTS8 | ENERGY BIOSYSTEMS CORPORATION (US) | 1998-12-08 | — | — | US | disclosed |
| US-5811285-A | DNA MOLECULE WHICH CODES BIOCATALYST WHICH SELECTIVELY DESULFURIZES FOSSIL FUEL CONTAINING SULFUR | ENERGY BIOSYSTEMS CORPORATION (US) | 1998-09-22 | — | — | US | disclosed |
| EP-0851928-A1 | DszD UTILIZATION IN DESULFURIZATION OF DBT BY RHODOCOCCUS sp. IGTS8 | ENERGY BIOSYSTEMS CORPORATION (US) | 1998-07-08 | — | — | EP | disclosed |
| WO-1997011185-A1 | DszD UTILIZATION IN DESULFURIZATION OF DBT BY RHODOCOCCUS sp. IGTS8 | ENERGY BIOSYSTEMS CORPORATION (US) | 1997-03-27 | — | — | WO | disclosed |
| US-5484708-A | DETERMINATION OF GLUCOSE | BOEHRINGER MANNHEIM GMBH (DE) | 1996-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174688-A1 | COMPOUND, (CO)POLYMER, COMPOSITION, METHOD FOR FORMING RESIST PATTERN, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING (CO)POLYMER | MCCC2, MMAB, INTS9 | ALDH1A1 1392/4885RECQL 3643/4885HSD17B10 575/4885 |
| US-20220119336-A1 | COMPOUND, (CO)POLYMER, COMPOSITION, METHOD FOR FORMING PATTERN, AND METHOD FOR PRODUCING COMPOUND | PYM1, MMAB, MEN1 | ALDH1A1 1455/4885RECQL 3079/4885HSD17B10 1729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.